173 related articles for article (PubMed ID: 18556686)
1. Statin use and risk of prostate cancer: results from a population-based epidemiologic study.
Agalliu I; Salinas CA; Hansten PD; Ostrander EA; Stanford JL
Am J Epidemiol; 2008 Aug; 168(3):250-60. PubMed ID: 18556686
[TBL] [Abstract][Full Text] [Related]
2. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
3. Statin Use and Prostate Cancer Incidence in Manitoba, Canada: A Population-Based Nested Case-Control Study.
Righolt CH; Bisewski R; Mahmud SM
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1765-1768. PubMed ID: 31387966
[TBL] [Abstract][Full Text] [Related]
4. Statin use and prostate cancer risk in a large population-based setting.
Boudreau DM; Yu O; Buist DS; Miglioretti DL
Cancer Causes Control; 2008 Sep; 19(7):767-74. PubMed ID: 18322813
[TBL] [Abstract][Full Text] [Related]
5. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
6. Statin and NSAID use and prostate cancer risk.
Coogan PF; Kelly JP; Strom BL; Rosenberg L
Pharmacoepidemiol Drug Saf; 2010 Jul; 19(7):752-5. PubMed ID: 20582910
[TBL] [Abstract][Full Text] [Related]
7. Statin use and risk of prostate cancer in the California Men's Health Study cohort.
Flick ED; Habel LA; Chan KA; Van Den Eeden SK; Quinn VP; Haque R; Orav EJ; Seeger JD; Sadler MC; Quesenberry CP; Sternfeld B; Jacobsen SJ; Whitmer RA; Caan BJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2218-25. PubMed ID: 17971519
[TBL] [Abstract][Full Text] [Related]
8. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-lowering drugs and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2226-32. PubMed ID: 18006910
[TBL] [Abstract][Full Text] [Related]
10. The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study.
Dawe DE; Ye X; Czaykowski P; Jassal D; Singh H; Skarsgard D; Aprikian A; Mahmud SM
Int J Cancer; 2018 Jul; 143(1):190-198. PubMed ID: 29405283
[TBL] [Abstract][Full Text] [Related]
11. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
Bonovas S; Filioussi K; Sitaras NM
Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
[TBL] [Abstract][Full Text] [Related]
12. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
13. Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study.
Lustman A; Nakar S; Cohen AD; Vinker S
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):6-9. PubMed ID: 24061633
[TBL] [Abstract][Full Text] [Related]
14. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins.
Vettenranta A; Murtola TJ; Raitanen J; Raittinen P; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
JAMA Oncol; 2022 Jan; 8(1):61-68. PubMed ID: 34817559
[TBL] [Abstract][Full Text] [Related]
16. Statins and prostate cancer diagnosis and grade in a veterans population.
Farwell WR; D'Avolio LW; Scranton RE; Lawler EV; Gaziano JM
J Natl Cancer Inst; 2011 Jun; 103(11):885-92. PubMed ID: 21498780
[TBL] [Abstract][Full Text] [Related]
17. Obesity and the risk of prostate cancer.
Porter MP; Stanford JL
Prostate; 2005 Mar; 62(4):316-21. PubMed ID: 15389806
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering drugs and advanced prostate cancer incidence in a large U.S. cohort.
Jacobs EJ; Rodriguez C; Bain EB; Wang Y; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2213-7. PubMed ID: 17971518
[TBL] [Abstract][Full Text] [Related]
19. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer.
Allott EH; Ebot EM; Stopsack KH; Gonzalez-Feliciano AG; Markt SC; Wilson KM; Ahearn TU; Gerke TA; Downer MK; Rider JR; Freedland SJ; Lotan TL; Kantoff PW; Platz EA; Loda M; Stampfer MJ; Giovannucci E; Sweeney CJ; Finn SP; Mucci LA
Clin Cancer Res; 2020 Mar; 26(5):1086-1093. PubMed ID: 31754047
[TBL] [Abstract][Full Text] [Related]
20. Statin Use and Lower Urinary Tract Symptoms Incidence and Progression in Reduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial.
Kramer JJ; Gu L; Moreira D; Andriole G; Csizmadi I; Freedland SJ
J Urol; 2022 Feb; 207(2):417-423. PubMed ID: 34544265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
